Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.
about
Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.Clinical efficacy of including capecitabine in neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis of randomized controlled trials.Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study.
P2860
Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase II study of docetaxel, c ...... ocally advanced breast cancer.
@ast
Phase II study of docetaxel, c ...... ocally advanced breast cancer.
@en
type
label
Phase II study of docetaxel, c ...... ocally advanced breast cancer.
@ast
Phase II study of docetaxel, c ...... ocally advanced breast cancer.
@en
prefLabel
Phase II study of docetaxel, c ...... ocally advanced breast cancer.
@ast
Phase II study of docetaxel, c ...... ocally advanced breast cancer.
@en
P2093
P2860
P50
P1476
Phase II study of docetaxel, c ...... ocally advanced breast cancer.
@en
P2093
Chia-Ming Hsieh
Dah-Cherng Yeh
Dar-Ren Chen
Hsien-Tang Yeh
Hwei-Chung Wang
Ling-Min Tseng
Yen-Shen Lu
P2860
P2888
P304
P356
10.1007/S00280-010-1401-2
P577
2010-08-11T00:00:00Z
P6179
1037875844